Annals of Nuclear Medicine

Papers
(The TQCC of Annals of Nuclear Medicine is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
68Ga-FAPI-04 PET/CT, a new step in breast cancer imaging: a comparative pilot study with the 18F-FDG PET/CT85
Superiority of 68Ga-FAPI PET/CT scan in detecting additional lesions compared to 18FDG PET/CT scan in breast cancer51
18F-choline PET/CT and PET/MRI in primary and recurrent hyperparathyroidism: a systematic review of the literature41
Non-local mean denoising using multiple PET reconstructions40
Digital PET/CT allows for shorter acquisition protocols or reduced radiopharmaceutical dose in [18F]-FDG PET/CT36
Detection of sub-centimeter lesions using digital TOF-PET/CT system combined with Bayesian penalized likelihood reconstruction algorithm34
Characterization of the benign lesions with increased 68Ga-FAPI-04 uptake in PET/CT33
A review on AI in PET imaging31
The 2020 national diagnostic reference levels for nuclear medicine in Japan28
FDG-PET biomarkers associated with long-term benefit from first-line immunotherapy in patients with advanced non-small cell lung cancer26
Preoperative prediction of regional lymph node metastasis of colorectal cancer based on 18F-FDG PET/CT and machine learning26
Prediction of local recurrence and distant metastasis using radiomics analysis of pretreatment nasopharyngeal [18F]FDG PET/CT images25
Prognostic value of 18F-FDG PET/CT with texture analysis in patients with rectal cancer treated by surgery24
Development of Convolutional Neural Networks to identify bone metastasis for prostate cancer patients in bone scintigraphy24
The role of FDG PET/CT or PET/MRI in assessing response to neoadjuvant therapy for patients with borderline or resectable pancreatic cancer: a systematic literature review24
High detection rate in [18F]PSMA-1007 PET: interim results focusing on biochemical recurrence in prostate cancer patients24
Prediction of HER2 expression in breast cancer by combining PET/CT radiomic analysis and machine learning21
Extended single-dose toxicity study of [211At]NaAt in mice for the first-in-human clinical trial of targeted alpha therapy for differentiated thyroid cancer21
[18F]FDG PET/MRI in rectal cancer20
Prognostic significance of 68Ga-Pentixafor PET/CT in multiple myeloma recurrence: a comparison to 18F-FDG PET/CT and laboratory results18
Evaluation of F-18 DOPA PET/CT in the detection of recurrent or metastatic medullary thyroid carcinoma: comparison with GA-68 DOTA-TATE PET/CT18
18F-FDG PET/CT of off-target lymphoid organs in CD19-targeting chimeric antigen receptor T-cell therapy for relapsed or refractory diffuse large B-cell lymphoma18
Clinical impact of 68Ga-DOTATATE PET-CT imaging in patients with medullary thyroid cancer17
Preoperative F-18 fluorocholine PET/CT for the detection of hyperfunctioning parathyroid glands in patients with secondary or tertiary hyperparathyroidism: comparison with Tc-99m sestamibi scan and ne17
68Ga-DOTA-FAPI-04 PET/CT imaging in radioiodine-refractory differentiated thyroid cancer (RR-DTC) patients17
Prostate-specific membrane antigen and fibroblast activation protein distribution in prostate cancer: preliminary data on immunohistochemistry and PET imaging17
Deep learning-based attenuation correction for brain PET with various radiotracers17
Validation of the 3-variable prognostic score (3-PS) in mCRPC patients treated with 223Radium-dichloride: a national multicenter study15
Therapeutic efficacy of 225Ac-PSMA-617 targeted alpha therapy in patients of metastatic castrate resistant prostate cancer after taxane-based chemotherapy15
Does bone scintigraphy still have a role in the era of 68 Ga-PSMA PET/CT in prostate cancer?15
Improvement in cognitive decline after indirect bypass surgery in adult moyamoya disease: implication of 15O-gas positron emission tomography14
Prognostic value of the baseline 18F-FDG PET/CT metabolic tumour volume (MTV) and further stratification in low-intermediate (L-I) and high-intermediate (H-I) risk NCCNIPI subgroup by MTV in DLBCL MTV14
The impact of data-driven respiratory gating in clinical F-18 FDG PET/CT: comparison of free breathing and deep-expiration breath-hold CT protocol14
Manual on the proper use of sodium astatide ([211At]NaAt) injections in clinical trials for targeted alpha therapy (1st edition)14
The utility of a deep learning-based algorithm for bone scintigraphy in patient with prostate cancer14
Prognostic value of tumor metabolic imaging phenotype by FDG PET radiomics in HNSCC14
131I-MIBG negative progressive symptomatic metastatic paraganglioma: response and outcome with 177Lu-DOTATATE peptide receptor radionuclide therapy13
Revisiting detection of in-transit metastases in melanoma patients using digital 18F-FDG PET/CT with small-voxel reconstruction13
The prognostic role of end-of-treatment FDG-PET/CT in diffuse large B cell lymphoma: a pilot study application of neural networks to predict time-to-event13
Comparison of 18F-FDG PET/CT and 67Ga-SPECT for the diagnosis of fever of unknown origin: a multicenter prospective study in Japan13
An overview of the developments and potential applications of 68Ga-labelled PET/CT hypoxia imaging12
Prognostic value of total tumour volume, adding necrosis to metabolic tumour volume, in advanced or metastatic non-small cell lung cancer treated with first-line pembrolizumab12
Clinical practice guidelines for high-resolution breast PET, 2019 edition12
Can PSMA-based tumor burden predict response to docetaxel treatment in metastatic castration-resistant prostate cancer?12
Role of traditional CHO PET parameters in distinguishing IDH, TERT and MGMT alterations in primary diffuse gliomas12
Temporal metabolic response to mRNA COVID-19 vaccinations in oncology patients12
[18F]FDG uptake in axillary lymph nodes and deltoid muscle after COVID-19 mRNA vaccination: a cohort study to determine incidence and contributing factors using a multivariate analysis12
Artificial intelligence for nuclear medicine in oncology12
Performance evaluation of dedicated brain PET scanner with motion correction system11
Deep learning for image classification in dedicated breast positron emission tomography (dbPET)11
Impact of the new ultra-high sensitivity mode in a long axial field-of-view PET/CT11
A different overview of staging PET/CT images in patients with esophageal cancer: the role of textural analysis with machine learning methods11
Diagnostic performance of whole-body bone scintigraphy in combination with SPECT/CT for detection of bone metastases11
Attenuation correction using deep learning for brain perfusion SPECT images11
Recent advances in cardiac positron emission tomography for quantitative perfusion analyses and molecular imaging11
Targeted alpha immunotherapy of CD20-positive B-cell lymphoma model: dosimetry estimate of 225Ac-DOTA-rituximab using 64Cu-DOTA-rituximab10
Comparison of 68Ga-DOTANOC PET/CT with cardiac MRI in patients with clinical suspicion of cardiac sarcoidosis10
Reactor produced [64Cu]CuCl2 as a PET radiopharmaceutical for cancer imaging: from radiochemistry laboratory to nuclear medicine clinic10
Investigation of perfusion defects by Q-SPECT/CT in patients with mild-to-moderate course of COVID-19 and low clinical probability for pulmonary embolism10
Manual on the proper use of meta-[211At] astato-benzylguanidine ([211At] MABG) injections in clinical trials for targeted alpha therapy (1st edition)10
Feasibility of ultra-high-speed acquisition in xSPECT bone algorithm: a phantom study with advanced bone SPECT-specific phantom10
Quantitative evaluation of anti-resorptive agent-related osteonecrosis of the jaw using bone single photon emission computed tomography in clinical settings: relationship between clinical stage and im10
Development and validation of a prediction model based on the organ-based metabolic tumor volume on FDG-PET in patients with differentiated thyroid carcinoma9
Initial evaluation of a new maximum-likelihood attenuation correction factor-based attenuation correction for time-of-flight brain PET9
Predictive factors of tumor sink effect: Insights from 177Lu-Prostate-specific membrane antigen therapy9
Metabolic tumor volume predicts long-term survival after transplantation for unresectable colorectal liver metastases: 15 years of experience from the SECA study9
Whole-body vibration exercise and training increase regional CBF in mild cognitive impairment with enhanced cognitive function9
Value of volumetric and textural analysis in predicting the treatment response in patients with locally advanced rectal cancer9
The contribution of metabolic parameters of FDG PET/CT prior and during therapy of adult patients with lymphomas9
Deep learning exploration for SPECT MPI polar map images classification in coronary artery disease9
Prognostic and predictive values of interim 18F-FDG PET during neoadjuvant chemoradiotherapy for esophageal cancer: a systematic review and meta-analysis9
The application of artificial intelligence in nuclear cardiology9
Current status of radioligand therapy and positron-emission tomography with prostate-specific membrane antigen8
Bone scintigraphy as a gatekeeper for the detection of bone metastases in patients with prostate cancer: comparison with Ga-68 PSMA PET/CT8
Test–retest repeatability of quantitative bone SPECT/CT8
Association of tau accumulation and atrophy in mild cognitive impairment: a longitudinal study8
Pretreatment [18F]FDG PET/CT and MRI in the prognosis of nasopharyngeal carcinoma8
Generative image transformer (GIT): unsupervised continuous image generative and transformable model for [123I]FP-CIT SPECT images8
An open-label, single-arm, multi-center, phase II clinical trial of single-dose [131I]meta-iodobenzylguanidine therapy for patients with refractory pheochromocytoma and paraganglioma8
Metal artifact reduction for improving quantitative SPECT/CT imaging8
Pretreatment 18F-FDG uptake heterogeneity can predict treatment outcome of carbon ion radiotherapy in patients with locally recurrent nasopharyngeal carcinoma8
Targeted radioimmunotherapy with the iodine-131-labeled caerin 1.1 peptide for human anaplastic thyroid cancer in nude mice8
Safety and efficacy of peptide receptor radionuclide therapy with 177Lu-DOTA0-Tyr3-octreotate in combination with amino acid solution infusion in Japanese patients with somatostatin receptor-positive,8
68Ga-PSMA-11 PET imaging in patients with ongoing androgen deprivation therapy for advanced prostate cancer7
New standards for phantom image quality and SUV harmonization range for multicenter oncology PET studies7
Comparison between dynamic whole-body FDG-PET and early-delayed imaging for the assessment of motion in focal uptake in colorectal area7
Application of artificial intelligence in brain molecular imaging7
Sentinel lymph node biopsy in muscle-invasive bladder cancer: single-center experience7
Tumor glycolytic heterogeneity improves detection of regional nodal metastasis in patients with lung adenocarcinoma7
Evaluating and comparing the image quality and quantification accuracy of SiPM-PET/CT and PMT-PET/CT7
Predictive value of multiple metabolic and heterogeneity parameters of 18F-FDG PET/CT for EGFR mutations in non-small cell lung cancer7
Automatic quantification package (Hone Graph) for phantom-based image quality assessment in bone SPECT: computerized automatic classification of detectability7
Value of 18F-FDG PET/CT for prognostic stratification in patients with primary intestinal diffuse large B cell lymphoma treated with an R-CHOP-like regimen7
Crossed cerebellar diaschisis: risk factors and prognostic value in focal cortical dysplasia by 18F-FDG PET/CT7
Determining the extent of tumor resection at surgical planning with 18F-fluciclovine PET/CT in patients with suspected glioma: multicenter phase III trials7
Recent topics of the clinical utility of PET/MRI in oncology and neuroscience7
18F FDG-PET/CT analysis of spread through air spaces (STAS) in clinical stage I lung adenocarcinoma7
Deep learning-based detection of parathyroid adenoma by 99mTc-MIBI scintigraphy in patients with primary hyperparathyroidism7
What radiolabeled FAPI pet can add in breast cancer? A systematic review from literature7
18F-FLT PET/CT imaging for early monitoring response to CDK4/6 inhibitor therapy in triple negative breast cancer7
Diagnostic efficiency of hybrid imaging using PSMA ligands, PET/CT, PET/MRI and MRI in identifying malignant prostate lesions7
Dual time point imaging of staging PSMA PET/CT quantification; spread and radiomic analyses7
Relapse-free survival after adjuvant radioactive iodine therapy in patients with differentiated thyroid carcinoma with a microscopically positive tumor margin6
Effect of sex on aging-related decline of dopamine transporter in healthy subjects6
Prognostic value of 18F-FDG PET/MRI in patients with advanced oropharyngeal and hypopharyngeal squamous cell carcinoma6
A review of harmonization strategies for quantitative PET6
High-dose 131I-mIBG as consolidation therapy in pediatric patients with relapsed neuroblastoma and ganglioneuroblastoma: the Japanese experience6
Patient dosimetry of 177Lu-PSMA I&T in metastatic prostate cancer treatment: the experience in Thailand6
Diagnostic value of [18F]Fluorocholine PET/CT in detection of primary medullary thyroid cancer6
Correlations between whole body volumetric parameters of 68Ga-PSMA PET/CT and biochemical-histopathological parameters in castration-naive and resistant prostate cancer patients6
Opportunistic skeletal muscle metrics as prognostic tools in metastatic castration-resistant prostate cancer patients candidates to receive Radium-2236
Assessing the effects of body weight on subchondral bone formation with quantitative 18F-sodium fluoride PET6
Detection of Alzheimer’s disease using ECD SPECT images by transfer learning from FDG PET6
Physiological 18F-FDG uptake in the normal adult anal canal: evaluation by PET/CT6
Test–retest reproducibility of dopamine transporter density measured with [18F]FP-CIT PET in patients with essential tremor and Parkinson’s disease6
Performance of digital PET/CT compared with conventional PET/CT in oncologic patients: a prospective comparison study6
Discontinuation of metformin to prevent metformin-induced high colonic FDG uptake: is 48 h sufficient?6
99mTc-PSMA targeted robot-assisted radioguided surgery during radical prostatectomy and extended lymph node dissection of prostate cancer patients6
18F-FDG uptake as a predictive factor for progressive aortic enlargement in aortic dissection6
Explorative analysis of a score predicting the therapy response of patients with metastatic, castration resistant prostate cancer undergoing radioligand therapy with 177Lu-labeled prostate-specific me6
Cellular S values in spindle-shaped cells: a dosimetry study on more realistic cell geometries using Geant4-DNA Monte Carlo simulation toolkit6
11C-Methionine PET/CT in patients with primary hyperparathyroidism and inconclusive pre-operative imaging work-up: diagnostic accuracy and role of semi-quantitative analysis6
Causes of false negatives in technetium-99 m methoxyisobutylisonitrile scintigraphy for hyperparathyroidism: influence of size and cysts in parathyroid lesions6
Diagnostic performance of 68Ga-DOTATOC PET/CT in tumor-induced osteomalacia6
Brain partial volume correction with point spreading function reconstruction in high-resolution digital PET: comparison with an MR-based method in FDG imaging6
The role of Ga68 PSMA PET/CT imaging in Lu177 PSMA treatment planning in metastatic castration-resistant prostate cancer6
Optimal relaxation parameters of dynamic row-action maximum likelihood algorithm and post-smoothing filter for image reconstruction of dedicated breast PET6
Optimization of injection dose in 18F-FDG PET/CT based on the 2020 national diagnostic reference levels for nuclear medicine in Japan6
0.037101030349731